The company got a big shot in the arm on July 12, when the U.S. Food and Drug Administration granted fast-track status to the Canadian company's Fluviral flu vaccine.

FORBES

Yesterday, the Food and Drug Administration granted it fast-track status, which should make it easier for Millennium Pharmaceuticals (nasdaq: MLNM - news - people ) to file all the paperwork necessary for approval.

FORBES: The Man Behind Millennium's Cancer Drug

Also, who predicted the fast track taken by starter Ivan Nova, one that resulted in a 16-4 season and No. 2 status behind C.

FORBES: Yanks Overachieved in 2011